We are live on ! Find out more
MAM

Martingale Asset Management Portfolio holdings

AUM $3.99B
1-Year Est. Return 22.65%
This Fund
S&P 500
This Quarter Est. Return
+3.06%
1 Year Est. Return
+22.65%
3 Year Est. Return
+77.2%
5 Year Est. Return
+114.11%
10 Year Est. Return
+351.19%
AUM
$3.93B
AUM Growth
-$42.4M
Cap. Flow
-$91.1M
Cap. Flow %
-2.32%
Top 10 Hldgs %
12.14%
Holding
853
New
97
Increased
289
Reduced
356
Closed
83

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$18.2M
2
VLO icon
Valero Energy
VLO
+$10M
3
INCY icon
Incyte
INCY
+$9.41M
4
AMP icon
Ameriprise Financial
AMP
+$8.9M
5
DIS icon
Walt Disney
DIS
+$8.47M

Sector Composition

Rank Sector Weight
1 Financials 18.99%
2 Technology 17.12%
3 Healthcare 13.14%
4 Industrials 11.76%
5 Consumer Staples 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMPH icon
676
Amphastar Pharmaceuticals
AMPH
$872M
$332K 0.01%
12,400
-6,121
-33% -$158K
YOU icon
677
Clear Secure
YOU
$5.36B
$328K 0.01%
+9,364
New +$319K
MATV icon
678
Mativ Holdings
MATV
$645M
$328K 0.01%
+26,960
New +$318K
LUMN icon
679
Lumen
LUMN
$6.35B
$326K 0.01%
+41,945
New +$345K
PSFE icon
680
Paysafe
PSFE
$377M
$325K 0.01%
40,230
-328
-0.8% -$3.18K
HLF icon
681
Herbalife
HLF
$1.18B
$322K 0.01%
+25,015
New +$265K
WSBF icon
682
Waterstone Financial
WSBF
$375M
$321K 0.01%
+19,417
New +$305K
TNET icon
683
TriNet
TNET
$3.09B
$321K 0.01%
5,428
+14
+0.3% +$832
REPX icon
684
Riley Exploration Permian
REPX
$732M
$317K 0.01%
12,002
-13,026
-52% -$346K
VMD icon
685
Viemed Healthcare
VMD
$361M
$316K 0.01%
42,483
+2,399
+6% +$16.4K
RIGL icon
686
Rigel Pharmaceuticals
RIGL
$727M
$315K 0.01%
+7,360
New +$277K
DAWN
687
DELISTED
Day One Biopharmaceuticals
DAWN
$314K 0.01%
33,700
OPRT icon
688
Oportun Financial
OPRT
$368M
$313K 0.01%
59,162
-4
-0% -$21
SPOK icon
689
Spok Holdings
SPOK
$234M
$313K 0.01%
23,694
-9,182
-28% -$130K
PEBO icon
690
Peoples Bancorp
PEBO
$1.49B
$312K 0.01%
10,400
-500
-5% -$14.9K
FDBC icon
691
Fidelity D&D Bancorp
FDBC
$312M
$312K 0.01%
+7,173
New +$318K
HXL icon
692
Hexcel
HXL
$7.89B
$312K 0.01%
4,217
+407
+11% +$28.8K
PRAX icon
693
Praxis Precision Medicines
PRAX
$10.2B
$311K 0.01%
+1,056
New +$197K
PHIN icon
694
Phinia Inc
PHIN
$2.77B
$311K 0.01%
+4,955
New +$274K
NRDS icon
695
NerdWallet
NRDS
$575M
$307K 0.01%
22,679
-2,940
-11% -$38.5K
DNLI icon
696
Denali Therapeutics
DNLI
$3.89B
$306K 0.01%
+18,535
New +$313K
BY icon
697
Byline Bancorp
BY
$1.78B
$301K 0.01%
+10,322
New +$290K
ASB icon
698
Associated Banc-Corp
ASB
$5.91B
$299K 0.01%
+11,608
New +$299K
CZNC icon
699
Citizens & Northern Corp
CZNC
$451M
$295K 0.01%
+14,619
New +$291K
MLR icon
700
Miller Industries
MLR
$625M
$293K 0.01%
+7,835
New +$305K

Similar funds

Martingale Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Martingale Asset Management held 853 positions worth $3.93B, down 1.1% from $3.98B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Martingale Asset Management's Q4 2025 filing shows 97 new, 289 increased, 356 reduced and 83 closed positions. Its largest new stake was Smithfield Foods: 343,963 shares worth $7.68M. The largest sale was Curtiss-Wright, an estimated $24.8M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Martingale Asset Management's largest Q4 2025 buy was Smithfield Foods: 343,963 shares worth $7.68M.
  • Martingale Asset Management added most to TJX Companies in Q4 2025, an estimated $18.2M increase.
  • Martingale Asset Management's biggest Q4 2025 reduction was Curtiss-Wright, cutting an estimated $24.8M.
  • Martingale Asset Management fully exited Electronic Arts in Q4 2025, selling an estimated $23.4M.
  • Martingale Asset Management's ten largest holdings make up 12% of its $3.93B portfolio in Q4 2025.
  • Martingale Asset Management opened 97 new positions and closed 83 in Q4 2025.
  • Martingale Asset Management's portfolio value fell 1.1% quarter-over-quarter to $3.93B.

Based on Martingale Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.